Cargando…
Immunoglobulin A Mucosal Immunity and Altered Respiratory Epithelium in Cystic Fibrosis
The respiratory epithelium represents the first chemical, immune, and physical barrier against inhaled noxious materials, particularly pathogens in cystic fibrosis. Local mucus thickening, altered mucociliary clearance, and reduced pH due to CFTR protein dysfunction favor bacterial overgrowth and ex...
Autores principales: | Gohy, Sophie, Moeremans, Alexandra, Pilette, Charles, Collin, Amandine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700636/ https://www.ncbi.nlm.nih.gov/pubmed/34944110 http://dx.doi.org/10.3390/cells10123603 |
Ejemplares similares
-
Airway Epithelium Dysfunction in Cystic Fibrosis and COPD
por: De Rose, Virginia, et al.
Publicado: (2018) -
Lung immunoglobulin A immunity dysregulation in cystic fibrosis
por: Collin, Amandine M., et al.
Publicado: (2020) -
Secretory Immunoglobulin A Immunity in Chronic Obstructive Respiratory Diseases
por: de Fays, Charlotte, et al.
Publicado: (2022) -
Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond
por: Mall, Marcus A., et al.
Publicado: (2023) -
Therapeutic endobronchial resection of a benign tumor in a patient with cystic fibrosis
por: Gohy, Sophie, et al.
Publicado: (2019)